SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Edgemode entered into a Securities Purchase Agreement on July 8, 2026, issuing an unsecured convertible promissory note with principal of $129,600 (net proceeds $100,000) bearing 15% interest and maturing April 15, 2027. While the note is convertible into common stock upon default, the primary transaction is the creation of a direct financial obligation.
View raw filing on EDGAR →The filing discloses an unregistered private placement of 216,537 shares of Series A Convertible Preferred Stock under Regulation D Rule 506(b), generating $2.1 million in gross proceeds. This is a classic dilutive equity issuance to accredited investors as part of an ongoing $200 million offering, filed under Item 3.02 which is the standard disclosure vehicle for unregistered equity sales. The convertible nature and scale of the offering make it material to investors assessing the company's capital structure and dilution.
View raw filing on EDGAR →Stan Guidroz was appointed Chief Operating Officer of Accel Entertainment effective July 14, 2026, representing a material appointment to a C-suite operational leadership role.
View raw filing on EDGAR →Stockholders approved four material proposals at a Special Meeting: (1) authorization of share issuance upon conversion of $72 million in convertible notes and exercise of 135.8 million warrants; (2) amendment and restatement of the 2019 Incentive Award Plan increasing authorized shares; (3) charter amendment increasing authorized shares from 700 million to 4 billion; and (4) reverse stock split amendments. Vote tallies were disclosed for each proposal.
View raw filing on EDGAR →The disclosure centers on two material financial actions: (1) settlement of approximately $3.3 million in legacy liabilities for $550,000 cash, yielding an anticipated $2.75 million gain from extinguishment of indebtedness, and (2) board approval of a 1-for-4 reverse stock split to support NYSE American compliance. While the reverse stock split is a governance/capital structure action, the primary focus of the press release is the balance sheet improvement through debt settlement and the resulting accounting gain. This is a material financial event—the debt settlement substantially reduces obligations and improves stockholders' equity—but does not fit neatly into the specific financial categories (debt_issuance, dividend_distribution, material_impairment, etc.), making financial_other the most appropriate classification.
View raw filing on EDGAR →Curaleaf announced that exchange-traded options on its shares are commencing trading on the Montréal Exchange, an exchange-initiated listing that reflects the company's market maturity and institutional relevance. While this is a capital markets milestone, it is not a discrete M&A, financing, or governance event; rather, it is an operational/strategic development that enhances market infrastructure around the company's equity. The company explicitly states it did not apply for the listing and does not control it, and the listing involves no issuance of securities or proceeds to the company. This is material to investors as it expands available trading strategies and liquidity, but it is best classified as an operational milestone rather than a specific financial or governance event.
View raw filing on EDGAR →Curaleaf announced that Spain's AEMPS has approved registration of two standardized cannabis preparations (THC-dominant and CBD-dominant) developed by its Spanish subsidiary, making Curaleaf the first company to register under Spain's new Royal Decree 903/2025 framework. This is a material regulatory milestone that opens a pharmaceutical-grade distribution pathway through hospital pharmacies in a major European market (50 million people), reinforcing the company's strategic position in regulated international cannabis markets and supporting its long-term growth in Europe.
View raw filing on EDGAR →Kyle Callaway was appointed Chief Accounting Officer effective July 10, 2026, a named executive officer role. The disclosure centers on the appointment action itself—a promotion from Controller to CAO—with detailed background on his qualifications and prior experience. This is a material executive appointment that would affect investor assessment of the company's financial leadership and accounting oversight.
View raw filing on EDGAR →The disclosure centers on the Board's appointment of Gregory L. Heston as a Class III director effective July 10, 2026, filling a vacancy created by David Kornblatt's resignation. While the resignation is mentioned, the principal action disclosed is Heston's appointment to the Board and assignment to the Audit Committee. His extensive background as a retired EY audit partner with 38 years of public accounting experience and CPA credentials makes this a material governance event affecting the registrant's board composition and audit oversight.
View raw filing on EDGAR →Holley announced a voluntary $15 million prepayment of its first lien term loan facility, part of a broader $115 million deleveraging strategy since 2023. While this is a positive financial action (debt reduction funded by free cash flow), it does not fit the specific categories of debt_issuance (creation of new obligations), covenant_breach (violation of existing terms), or dividend_distribution. The disclosure emphasizes balance sheet transformation and financial flexibility, making it a material financial event that would inform investor assessment of the company's capital structure and leverage trajectory, but it is best classified as a financial event outside the named taxonomy categories.
View raw filing on EDGAR →The filing discloses management's unaudited estimates of net asset value per share ($9.83–$9.93), net investment income per share ($0.20–$0.28), and realized gain/loss per share (($0.65)–($0.57)) for the quarter ended June 30, 2026. This is a financial disclosure under Item 8.01 (Other Events) that provides material valuation and performance metrics to investors, though it does not fit the specific categories of earnings release, impairment, debt issuance, or other named financial events.
View raw filing on EDGAR →Catalyst Bancorp completed its acquisition of Lakeside Bancshares and Lakeside Bank effective July 14, 2026, for $41.1 million in cash ($19.58 per share). The transaction materially expanded Catalyst's asset base from $288.5 million to approximately $620 million and added four branch locations in Southwest Louisiana.
View raw filing on EDGAR →The disclosure reports results of the PJM capacity auction for 2028-2029, showing that all of Constellation's power plants cleared with 18,875 MW of total capacity at $325/MW. This is a material operational and financial event affecting future revenue streams, particularly for nuclear units whose capacity revenues factor into Production Tax Credit calculations. While not a traditional M&A, litigation, or governance matter, the auction results represent a significant market outcome affecting the company's operational and financial planning.
View raw filing on EDGAR →The filing discloses a change in special servicer for the Christiana Mall mortgage loan within the BBCMS 2018-CHRS securitization, effective July 14, 2026. Green Loan Services LLC replaces Trimont LLC as special servicer at the direction of Marathon Asset Management, the directing certificateholder. This is an operational/administrative change to loan servicing arrangements that would be material to investors in the securitization trust, as the special servicer's identity and performance directly affect loan administration and potential workout outcomes.
View raw filing on EDGAR →D-Wave voluntarily transferred its stock listing from NYSE to Nasdaq, effective July 24, 2026, with trading commencing on Nasdaq on July 27, 2026 under the same ticker "QBTS". The company has met all Nasdaq listing requirements and expects a smooth transition.
View raw filing on EDGAR →The disclosure announces a new time charter agreement for the vessel Mount Aconcagua for 16–18 months at an index-linked rate with a premium to the Baltic 5TC index and conversion rights to fixed rates. This is a material operational and commercial contract for a bulk carrier company, affecting vessel utilization and revenue generation, but does not fit the specific event categories (M&A, debt, equity issuance, etc.). It is clearly an operational/commercial milestone rather than a routine administrative matter.
View raw filing on EDGAR →The Sponsor has entered into two material definitive agreements—a Digital Asset Trading Agreement with StoneX Digital LLC and a Liquidity Provider Agreement with Virtu Financial Singapore Pte. Ltd.—to establish crypto asset trading counterparties for the Fund. These agreements establish ongoing principal-to-principal trading relationships for spot transactions in 17 eligible crypto assets and are disclosed under Item 1.01 (Entry into a Material Definitive Agreement), the standard Item for material contract entry. While not a traditional M&A transaction, the entry into these material trading agreements constitutes a material operational and financial commitment that would affect investor assessment of the Fund's trading infrastructure and counterparty relationships.
View raw filing on EDGAR →The filing discloses a distribution payment made on July 14, 2026, to holders of five classes of common stock (Class G, G-D, G-S, E, and I) at specified per-share amounts ranging from $0.1737 to $0.1900. This is a routine dividend distribution to shareholders, with amounts detailed in a table showing gross distributions and applicable servicing fees. The disclosure fits squarely within the dividend_distribution category.
View raw filing on EDGAR →The filing discloses results of a shareholder vote at the Fund's reconvened annual meeting held on July 14, 2026, specifically the election of Theodore L. Koenig as a Class I trustee. The voting results table shows 3,949,022 votes for, 0 votes withheld, and 0 broker non-votes, representing unanimous approval. This is a classic Item 5.07 shareholder vote results disclosure.
View raw filing on EDGAR →Lawson Whiting, President and Chief Executive Officer of Brown-Forman, announced his retirement effective upon appointment of a successor after nearly 30 years of service. The Board has initiated a search process for a successor.
View raw filing on EDGAR →PSCo filed a natural gas rate case seeking $190 million in revenue increase, and on July 13, 2026, a comprehensive non-unanimous settlement agreement was filed with the CPUC reducing the request to $123 million (7.5% increase) with a 9.2% ROE. This is a material regulatory milestone affecting PSCo's revenue and cost recovery, with final rates anticipated in Q4 2026. While regulatory proceedings are operational in nature, this settlement represents a significant business outcome that would affect investor assessment of the company's financial trajectory.
View raw filing on EDGAR →First Merchants Corporation declared a quarterly cash dividend of $46.88 per share ($0.4688 per depositary share) on its 7.50% Non-Cumulative Perpetual Preferred Stock Series A, payable August 14, 2026. This is a routine but material dividend declaration on preferred stock, which affects investor returns and is a standard disclosure under dividend_distribution.
View raw filing on EDGAR →Basin Electric disclosed a settlement agreement resolving previously disclosed disputes with McKenzie Electric Cooperative involving claims pending in North Dakota state court and before FERC. The settlement carries a pre-tax charge of approximately $40 million and involves dismissal of McKenzie's claims regarding buyout rights and Section 204 Federal Power Act complaints. This is a material litigation settlement that would affect a reasonable investor's assessment of the registrant's legal and financial position.
View raw filing on EDGAR →Diana Shipping Inc. announces an extension of its tender offer to acquire all outstanding shares of Genco Shipping & Trading Limited not already owned by Diana. The offer, valued at $27.34 per share ($24.80 cash plus one Diana share), represents a material acquisition activity. As of July 10, 2026, 11.1 million shares (29.7% of outstanding shares not owned by Diana) have been tendered. This is a direct M&A transaction with committed financing of $1.412 billion, representing a 53% premium to Genco's undisturbed share price, and would constitute a change of control if completed.
View raw filing on EDGAR →Robert Brackenbury was appointed to the Board of Directors as a Class I director on July 9, 2026, and will serve on the audit committee. The disclosure centers on the appointment of a new director with substantial experience in investment management and governance, making this a material executive appointment under Item 5.02.
View raw filing on EDGAR →Robin Rossmann was appointed Chief Financial Officer of CoStar Group effective July 31, 2026, succeeding Christian Lown. The appointment includes significant compensatory arrangements ($590,000 base salary, $2.5M equity grant, $500K relocation subsidy) and is material as it involves a key C-suite executive position.
View raw filing on EDGAR →This is a notice announcing the planned release of second quarter 2026 operating and financial results on August 6, 2026, with a management conference call scheduled for August 7, 2026. Although the actual results have not yet been disclosed, the exhibit is a formal announcement of an upcoming earnings release, which is a material event that would affect investor assessment of the company's quarterly performance.
View raw filing on EDGAR →Energy Fuels disclosed an investor presentation regarding expansion of its critical materials operations, including strategic initiatives in rare earths, uranium, and heavy mineral sands, as well as pending acquisitions (VAC and ASM). This is a material operational and strategic disclosure under Regulation FD, but does not fit a specific event category—it is neither a discrete M&A completion, earnings release, nor a single operational milestone, but rather a comprehensive strategic update on multiple business lines and growth projects.
View raw filing on EDGAR →Michael Nelson Gibbs, an Independent Director, retired from the Board of Directors effective July 12, 2026, completing his second consecutive term. The disclosure explicitly states he "retired from the Board" and "ceased to be the Chairperson of the Stakeholders Relationship Committee and the Cybersecurity Risk Sub-Committee, and a Member of the Audit Committee, Risk Management Committee, Nomination and Remuneration Committee, and Corporate Social Responsibility Committee." This is a clear departure of a director from the registrant's board, material to investors assessing governance and board composition.
View raw filing on EDGAR →The filing discloses the Board's authorization and declaration of a special cash dividend of $1.50 per share payable on July 31, 2026, to shareholders of record as of July 23, 2026. This is a material return of capital to shareholders. While the filing also mentions a share repurchase program authorization, the primary and most prominent disclosure is the special dividend declaration, which is a direct distribution to all shareholders.
View raw filing on EDGAR →Aaron Hefter resigned as Chief Brand Officer on July 7, 2026. The disclosure centers on a named executive officer leaving the company, with no appointment of a replacement mentioned. The position will remain vacant, making this a straightforward executive departure event.
View raw filing on EDGAR →Northern Oil and Gas issued a press release on July 13, 2026 disclosing preliminary financial and operating results for the second quarter of 2026, including hedging results, production volumes, capital expenditures, and shareholder returns. This is a classic Item 2.02 earnings release disclosure, furnished as Exhibit 99.1, providing material quarterly operational and financial updates that would affect a reasonable investor's assessment of the company's performance and cash flow generation.
View raw filing on EDGAR →The filing discloses the appointment of Anthony Pierce as a Class III director effective immediately, approved by the Board on July 9, 2026. While the disclosure also includes compensatory details (annual cash retainer of $55,000 and equity grant of $300,000), the principal action is the appointment itself. The Board expanded the authorized number of directors from 10 to 11 specifically to accommodate this appointment, making the directorship the salient event.
View raw filing on EDGAR →The Board of Directors adopted a comprehensive Policy on Shareholder Reimbursements and Payments that broadly prohibits the Company from reimbursing shareholder costs without 75% shareholder approval. The policy includes anti-circumvention provisions and requires public disclosure before any amendment, signaling a significant shift in the Company's governance framework that restricts its ability to settle disputes or enter into agreements with shareholders.
View raw filing on EDGAR →This press release discloses multiple material operational and development milestones for Vertical Aerospace's eVTOL aircraft program: successful piloted transition flights (described as "the most significant technical milestone in its history"), receipt of an expanded Permit to Fly from the UK CAA, completion of Critical Design Review by end of 2026, and a revised Type Certification timeline to 2029 (delayed from the previously indicated 2028 target). While the disclosure includes strategic partnerships and pre-order information, the core substance is operational progress on aircraft development and regulatory certification—a material update to investors on the company's path to commercialization that does not fit neatly into a single named event category but is clearly operational in nature.
View raw filing on EDGAR →Babcock & Wilcox Enterprises announced a Board-authorized share repurchase program of up to $50 million and the redemption of $61.4 million in 6.50% Senior Notes due 2026, representing capital allocation decisions reflecting management confidence in the company's financial position.
View raw filing on EDGAR →Armata announced FDA agreement on an Agreed Initial Pediatric Study Plan (iPSP) for AP-SA02, which the company characterizes as "an important regulatory milestone" on the path toward a future BLA. This is a material operational/regulatory milestone in the drug development process—it establishes the agreed framework for pediatric studies and is a prerequisite for BLA submission. While not a specific named event type (not earnings, M&A, impairment, etc.), it is clearly material to investors assessing the company's clinical development progress and regulatory pathway for its lead candidate.
View raw filing on EDGAR →TriCo Bancshares announced execution of a definitive Agreement and Plan of Reorganization and Merger with First Hawaiian, Inc., whereby First Hawaiian will acquire TriCo in an all-stock transaction at 2.095 FHI shares per TCBK share ($63.12 per share). The transaction creates a combined entity with ~$34 billion in assets and is expected to close by end of 2026, subject to regulatory and shareholder approvals. This is a material acquisition/change of control event requiring disclosure under Item 1.01 or 2.01, disclosed here via Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →First Hawaiian, Inc. disclosed preliminary second quarter 2026 financial results including net income of $73.4 million and diluted EPS of $0.60, subject to final closing procedures and auditor review with final earnings expected July 24, 2026.
View raw filing on EDGAR →First Hawaiian, Inc. executed a definitive Agreement and Plan of Reorganization and Merger to acquire TriCo Bancshares in an all-stock transaction at 2.095 FHB shares per TCBK share ($63.12 per share), creating a combined entity with approximately $34 billion in assets and making it the 6th largest bank headquartered in the Western U.S., with closing expected by end of 2026.
View raw filing on EDGAR →Plug Power entered into two material asset disposition transactions: (1) a definitive agreement to sell the Graham, Texas Project to Stream US Data Centers for up to $76.5 million (base $50 million plus up to $26.5 million earnout) with expected closing July 31, 2026, and (2) an amended purchase and sale agreement for the New York Gateway Project with a fixed purchase price of $142 million and staged closing structure extending to March 31, 2027. These dispositions are expected to deliver over $80 million in near-term liquidity as part of a broader $275 million strategic infrastructure optimization initiative.
View raw filing on EDGAR →This exhibit is a corporate presentation detailing Origin Agritech's turnaround strategy, leadership changes, R&D pipeline, and commercialization roadmap. While it includes executive appointments (CEO Weibin Yan in August 2024, CFO Dr. James Chen and Board member Dr. Jian Zhang in March 2026), the primary focus is on operational and strategic initiatives—market-oriented breeding, biotech commercialization, sales network rebuilding, supply chain upgrades, and a multi-year growth strategy (2024–2032). The disclosure emphasizes operational transformation and product development rather than discrete executive events. This is material to investors assessing the company's turnaround execution and competitive positioning in China's seed industry.
View raw filing on EDGAR →Alto Neuroscience announced acceleration and expansion of clinical development for ALTO-207, including an additional Phase 3 trial for treatment-resistant depression, representing a material strategic decision affecting the company's development trajectory and capital allocation.
View raw filing on EDGAR →Astrana Health disclosed 2024 ACO performance results showing $120.4 million in gross shared savings across all eight affiliated ACOs, with specific metrics on Medicare beneficiaries served and rankings. While this is operational performance data rather than a formal earnings release (which would typically be Item 2.02), the disclosure of material business performance metrics—particularly the company's core value-based care platform results—constitutes a significant operational event that would affect investor assessment of the company's strategic execution and competitive positioning in the healthcare market.
View raw filing on EDGAR →BNB Plus Corp. received a definitive delisting determination from the Nasdaq Hearing Panel due to non-compliance with the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Trading on Nasdaq will be suspended effective July 14, 2026, with the company transitioning to the OTCQB Venture Market, though the company intends to request a Listing Council Review.
View raw filing on EDGAR →Ocugen announced a binding term sheet to license OCU400 for retinitis pigmentosa in the Middle East and North Africa region, with cumulative sales milestones up to $255 million, upfront/development payments up to $4 million, and 22% royalties on net sales. This is a material strategic partnership and licensing arrangement that expands the company's geographic reach and revenue potential, but does not constitute a traditional M&A transaction (no acquisition, merger, or change of control). The event is clearly operational/strategic in nature—a significant commercial partnership—rather than fitting the specific M&A definition.
View raw filing on EDGAR →The Company declared a quarterly dividend of $0.0675 per share on common stock, payable July 30, 2026 to shareholders of record as of July 23, 2026. This is a routine but material capital distribution to shareholders that would affect investor assessment of the registrant's capital allocation and shareholder returns.
View raw filing on EDGAR →Edgewise completed the sale of its sevasemten compound and muscular dystrophy program to Servier Pharmaceuticals for $1.55 billion in upfront cash plus up to $1.1 billion in milestone payments (total consideration up to $2.65 billion), completed on July 10, 2026. This material disposition fundamentally reshapes the company's strategic focus toward cardiovascular programs.
View raw filing on EDGAR →Voyager disclosed positive preclinical GLP toxicology and efficacy data for VY1706 presented at the Alzheimer's Association International Conference, demonstrating favorable tolerability in non-human primates with up to 75% tau protein lowering and broad CNS delivery. This represents a material operational/clinical milestone for a gene therapy program advancing toward human trials (IND clearance received June 2026, dosing planned for H2 2026), affecting investor assessment of the company's pipeline progress and therapeutic potential.
View raw filing on EDGAR →James W. Roquemore, a Board member since 2022 (and previously 1994–2020), passed away on July 9, 2026. The disclosure explicitly states his death and his role as a director. This is a departure event triggered by death, which is material to investors as it affects board composition and governance.
View raw filing on EDGAR →